FASEB Growth Factor Receptor Tyrosine Kinases Confence
FASEB Growth Factor Receptor Tyrosine Kinases Confence
批准号:
6359929
负责人:
ALPHONSE E SIRICA
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2002-07-31
中文摘要
描述(由申请人提供)
此应用程序请求部分资金以支持第二次发行
一个独特的FASEB夏季研究会议上“生长因子受体
有丝分裂、形态发生和肿瘤发生中的酪氨酸激酶”将举行
2001年8月4日至8月9日在科罗拉多的斯诺马斯村举行。 基于
第一届FASEB夏季研究会议的总体重大成功
在1999年夏季举行的会议上,本次会议将继续重点讨论
在细胞和分子生物学和病理生理学的新发展,
生长因子酪氨酸激酶的重要类别,因为它们涉及
有丝分裂,组织再生和发育,形态发生,
肿瘤发生、进展以及侵袭和转移。 为配合
前与会者一致认为,erbB和Met家族的受体
将再次强调酪氨酸激酶。 此外,新的会议将
细胞外基质信号传导,受体酪氨酸激酶结构域
以及新型小药物开发、受体酪氨酸的治疗靶向
恶性疾病中的激酶,非恶性疾病中的生长因子疗法,
以及罗恩/Stk受体酪氨酸激酶的生物学和病理学。
该科学计划将包括25个邀请的平台介绍
发言者,其中大多数是该领域的知名领导人。 而且
该计划将包括大量选定的抽象驱动的口头
演讲,以及基于提交的摘要的海报会议。 一
青年研究者小型研讨会,这被证明是一个非常成功的
第一次会议的组成部分,将再次成为一个亮点,
目前的会议。 为了提供一个气候最大化的科学
与会者之间的互动,会议出席将限于
100至195名调查员(包括特邀发言人),
根据他们的专业知识和最近的贡献,
科学文献 将尽一切努力确保适当的组合,
建立和年轻的调查人员,特别是妇女和少数民族,
鼓励参与。 像第一次会议一样,第二次会议
预计会非常成功,并再次成为最先进的
生长因子受体酪氨酸激酶科学论坛,
为富有成效的新的研究互动的机会,以及满足
FASEB夏季研究会议的高标准。
英文摘要
DESCRIPTION (provided by applicant)
This application is requesting partial funding to support the second offering
of a unique FASEB Summer Research Conference on "Growth Factor Receptor
Tyrosine Kinases in Mitogenesis, Morphogenesis, and Tumorgenesis" to be held
at Snowmass Village, Colorado from August 4 to August 9, 2001. Based on the
overall major success of the first FASEB Summer Research Conference on this
subject held in the Summer 1999, the current Conference will continue to focus
on new developments in the cell and molecular biology and pathophysiology of
important classes of growth factor tyrosine kinases as they relate to
mitogenesis, tissue regeneration and development, morphogenesis,
tumorigenesis, progression, and invasion and metastasis. In line with the
unanimous view of previous attendees, the erbB and Met families of receptor
tyrosine kinases will again be emphasized. In addition, novel sessions will
be held on extracellular matrix signaling, receptor tyrosine kinase domains
and new small drug development, therapeutic targeting of receptor tyrosine
kinases in malignant disease, growth factor therapy in non-malignant diseases,
and on the biology and pathobiology of the Ron/Stk receptor tyrosine kinase.
The Scientific Program will include platform presentations by 25 Invited
Speakers, a majority of whom are renown leaders in the field. Moreover, the
program will include a significant number of selected Abstract-driven oral
presentations, as well as a Poster Session based on submitted abstracts. A
Young Investigator Mini-Symposium, which proved to be a highly successful
component of the first conference, will again serve as a highlight of the
current conference. In order to provide a climate maximizing scientific
interaction among the participants, conference attendance will be limited to
between 100 and 195 investigators (including Invited Speakers), selected from
applications based on their expertise and recent contributions to the
scientific literature. Every effort will be made to insure a proper mix of
established and young investigators, with women and minorities particularly
encourage to participate. Like the first conference, this second conference
is anticipated to be quite successful and to again serve as a state-of-the-art
scientific forum on growth factor receptor tyrosine kinases that will foster
opportunities for productive new research interactions as well as meet the
high standards of a FASEB Summer Research Conference.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
-
批准号:10747566
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2023
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7172654
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER
-
批准号:6023971
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6865103
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6693829
-
项目类别:
-
资助金额:$26.19万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7339683
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER
-
批准号:6350400
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:8499770
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7558284
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:8829763
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:9228939
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6628421
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6497936
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7009272
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
FASEB GROWTH FACTOR RECEPTOR TYROSINE KINASES CONFERENCE
-
批准号:2869480
-
项目类别:
-
资助金额:$0.9万
-
财政年份:1999
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:6137427
-
项目类别:
-
资助金额:$26.92万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:2089765
-
项目类别:
-
资助金额:$22.15万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:7812168
-
项目类别:
-
资助金额:$28.9万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:7305108
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:2633775
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位: